We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
51
Oracle
ORCL
$435B
$30.1M 0.34%
544,354
-14,079
-3% -$746K
UNP icon
52
Union Pacific
UNP
$174B
$30M 0.34%
177,470
-1,469
-0.8% -$235K
AMT icon
53
American Tower
AMT
$79.9B
$30M 0.34%
115,941
+1,767
+2% +$437K
LIN icon
54
Linde
LIN
$222B
$29.1M 0.33%
137,356
-1,108
-0.8% -$214K
DHR icon
55
Danaher
DHR
$146B
$29.1M 0.33%
185,637
-235
-0.1% -$33.7K
PM icon
56
Philip Morris
PM
$289B
$28.5M 0.32%
407,246
+6,200
+2% +$452K
IBM icon
57
IBM
IBM
$220B
$28M 0.32%
242,899
+4,114
+2% +$478K
C icon
58
Citigroup
C
$231B
$27.8M 0.32%
544,470
-18,276
-3% -$867K
EPD icon
59
Enterprise Products Partners
EPD
$81.8B
$27.7M 0.32%
1,525,270
QCOM icon
60
Qualcomm
QCOM
$171B
$26.8M 0.31%
294,210
-115
-0% -$9.22K
LOW icon
61
Lowe's Companies
LOW
$121B
$26.7M 0.3%
197,461
-107
-0.1% -$12.2K
HON icon
62
Honeywell
HON
$73.6B
$26.5M 0.3%
194,756
-659
-0.3% -$87.2K
BA icon
63
Boeing
BA
$182B
$25.5M 0.29%
139,036
+1,223
+0.9% +$188K
GILD icon
64
Gilead Sciences
GILD
$170B
$25.2M 0.29%
327,967
+1,860
+0.6% +$143K
ET icon
65
Energy Transfer Partners
ET
$71.8B
$25.1M 0.29%
3,525,882
WFC icon
66
Wells Fargo
WFC
$268B
$25M 0.28%
975,795
-16,261
-2% -$445K
LMT icon
67
Lockheed Martin
LMT
$139B
$23.6M 0.27%
64,543
+560
+0.9% +$212K
RTX icon
68
RTX Corp
RTX
$299B
$23.5M 0.27%
381,435
+49,134
+15% +$3.07M
MMM icon
69
3M
MMM
$94.8B
$23.5M 0.27%
179,920
+2,641
+1% +$333K
IWM icon
70
iShares Russell 2000 ETF
IWM
$82.2B
$22.9M 0.26%
160,200
-39,700
-20% -$5.21M
SBUX icon
71
Starbucks
SBUX
$123B
$22.5M 0.26%
305,501
+1,083
+0.4% +$81.4K
EFA icon
72
iShares MSCI EAFE ETF
EFA
$80.1B
$22.4M 0.25%
368,000
-329,000
-47% -$19M
CVS icon
73
CVS Health
CVS
$120B
$22.2M 0.25%
341,853
+6,513
+2% +$410K
BLK icon
74
Blackrock
BLK
$179B
$22M 0.25%
40,346
+9,947
+33% +$5.02M
FIS icon
75
Fidelity National Information Services
FIS
$21.5B
$21.7M 0.25%
161,586
+3,165
+2% +$416K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.